Award notice
Temporary Vascular Occlusion Clamp (TVOC)
FA238424CB015
Department of the Air Force, FA2384 USAF AFMC AFRL PZL AFRL Rakh. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Awarded
$7,453,975.00 on the award notice, September 30, 2024, contract FA238424CB015
Description
As published on SAM.gov.
Amsel Medical Corporation, Cambridge, MA, was awarded a $7,453,975.00 cost-plus--fixed-fee SBIR Phase III contract. This contract provides for the development of an FDA-approved temporary vacsular occlusion clamp. Work will be performed in Cambridge, Massachusetts, and is expected to be completed 30 March 2027.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Amsel Medical Corporation
- UEI
- UUM9WLJWJQ24
- CAGE
- 6PXF8
- Vendor location
- Cambridge, MA
- Contract
- FA238424CB015, definitive contract
- Obligated
- $5,510,840.58
- Actions
- 7 between September 30, 2024 and February 24, 2026
- Competition
- Full and Open Competition, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- Non-Surgical Control of Junctional and Non-Compressible Hemorrhage Via Percutaneously Delivered Adjustable Vessel Occlusion
- Match
- award number FA238424CB015 equals the contract number; same awarding office FA2384 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
September 30, 2024
Award notice
Awarded to AMSEL MEDICAL CORPORATION Cambridge for $7,453,975. SAM.gov, notice d2c681896e5a473da99e52c08bb8230e
Points of contact
- Alex LaVellealex.r.lavelle.4@us.af.mil